Angewandte
Communications
Chemie
Synthetic Methods
Palladium Catalysis Enables Benzylation of a,a-Difluoroketone
Enolates
Abstract: A palladium-catalyzed decarboxylative benzylation
reaction of a,a-difluoroketone enolates is reported, in which
3
À
the key C(a) C(sp ) bond is generated by reductive elimina-
tion from a palladium intermediate. The transformation
provides convergent access to a-benzyl-a,a-difluoroketone-
based products, and should be useful for accessing biological
probes.
T
he a,a-difluoroketone is a privileged substructure in
medicinal chemistry.[1] For this substructure, the electron-
withdrawing fluorine atoms encourage rehybridization of the
2
3
=
sp -hybridized C O to form sp -hybridized hydrates or hemi-
hydrates,[2] which can then interact with aspartyl proteases
through noncovalent hydrogen-bonding networks involving
water molecules, and with serine proteases through reversible
covalent interactions.[1] In addition, a subset of a-benzyl-a,a-
difluoroketone derivatives also have demonstrated choles-
terol-lowering,[3] analgesic,[4] anxiolytic,[5] and pro-inflamma-
tory[6] activities (Figure 1). Thus, convergent and mild strat-
egies for accessing a-benzyl-a,a-difluoroketone-based sub-
structures should be useful for developing new therapeutic
candidates and biological probes.
Figure 1. a-Benzyl-a,a-difluoroketone motifs in bioactive molecules.
icochemical properties that preclude formation of the
3
À
A convergent preparation of this substructure would
C(a) C(sp ) bond. Specifically, the strong inductive effect
3
À
involve a transformation capable of generating a C(a) C(sp )
of the two fluorine atoms[9a] decreases the charge density of an
enolate at the a-position,[9b] and thus reduces the nucleophi-
licity of the anion and disfavors reactions with sp3-based
electrophiles (Figure 2c). As a result, a,a-difluoroketone
enolates react by SN2 reactions at the O to generate
difluorovinyl ethers, instead of at C(a) (Figure 2d).[10]
Because of these two factors, only two manuscripts describe
SN1- or SN2-like alkylation reactions of a,a-difluoroketones,
and both require stoichiometric amounts of metal reagents to
promote the reactions (Figure 2e).[11]
Because of this intrinsically poor reactivity, several
alternative strategies for accessing a-benzyl-a,a-difluoroke-
tones have been developed, including: 1) deoxyfluorination
of a-ketoesters using strong fluorinating reagents, followed by
addition of organolithium or Grignard reagents to the
resulting a,a-difluoroester, for which the strong bases and
harsh reagents destroy many functional groups;[3] 2) 1,2-
addition of a-lithio-b,b-difluorovinyl ethers to aldehydes
followed by deoxygenation (or cyclization) of the resulting
alcohol, which only accesses a small subset of products;[12] 3) a
single radical addition reaction of an aldehyde to a (2,2-
difluorovinyl)benzene;[13] and 4) a late-stage electrophilic
difluorination of prefunctionalized imines using Selectfluor/
NFSI followed by acid-mediated hydrolysis—not a convergent
strategy, which also generates a mixture of fluorinated
products for substrates bearing two sites capable of under-
going imine-enamine isomerization.[14] However, none of
bond, presumably by reacting a nucleophilic a,a-difluoroke-
tone enolate with an sp3-hybridized benzylic electrophile
(Figure 2a). Alkylation of ketone enolates with sp3-based
electrophiles is a fundamental transformation for accessing
a broad spectrum of a-functionalized ketones.[7] However,
nucleophilic substitution reactions of a,a-difluorinated eno-
lates with sp3-based electrophiles have not been generally
developed, because of two problems. First, chemoselective
formation of a,a-difluoroketone enolates presents challenges,
because deprotonation of a,a-difluoromethyl ketones produ-
ces enolates at the nonfluorinated position under both
thermodynamic and kinetic conditions (Figure 2b),[8] and
upon trapping, cannot afford a-functionalized-a,a-difluoro-
ketones. Second, a,a-difluoroenolates possess unique phys-
[*] M.-H. Yang, J. R. Hunt, Prof. Dr. R. A. Altman
Department of Medicinal Chemistry
The University of Kansas
1251 Wescoe Hall Drive, Lawrence, KS 66045 (USA)
E-mail: raaltman@ku.edu
Dr. N. Sharifi
Department of Medicinal Chemistry, Faculty of Pharmacy
Tehran University of Medical Science
16 Azar St., Tehran 1417614411 (Iran)
Supporting information for this article can be found under:
Angew. Chem. Int. Ed. 2016, 55, 1 – 5
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!